BIOVIA

🥇 Like Olympic athletes, composite materials blend strength and flexibility for superior performance. They're lightweight, durable and ideal for crafting the next generation of high-performance footwear. Imagine shoes that are not only incredibly comfortable but also sustainable! Explore how advanced materials are shaping the future of footwear, from design to performance. Step into this blog to learn more: http://go.3ds.com/DD3.

How did a top pharma company eliminate manual data import steps while running clinical trials? We partnered with them to transform and automate their data collection, processing and analysis. With BIOVIA #PipelinePilot, they were able to: ✅ Automate quality check for input patient videos ✅ Automate video annotation, including patient de-identification for the protection of health information ✅ Leverage #AI and machine learning for video analytics leading to measurable, actionable insights ✅ Create easy-to-analyze interactive reports and charts allowing human validation when needed Learn more about this collaboration and how Pipeline Pilot enhanced decision-making, increased operational efficiency and productivity and saved time and resources: http://go.3ds.com/GlG.

Get in (chemically correct) shape! Properly drawing and representing chemical structures is not just about drawing pretty pictures — accuracy and correctness are critical in designing new chemical products. Ready to leverage the latest advancements in chemical drawing software? Discover how BIOVIA can support your research and development efforts: http://go.3ds.com/pfy.

How did Pfizer accelerate its research with BIOVIA #PipelinePilot? Tiffany Lai, a Senior Informatics Scientist at Pfizer’s Drug Product R&D team, shared how she used Pipeline Pilot for efficient data collection, organization and processing. Read the customer story to learn how they are: ✅Saving scientists 5-7 hours per week ✅Improving data consistency and quality by reducing errors ✅Simplifying analysis for effective, data-driven insights http://go.3ds.com/FTe

👇Leave your answer below:

☀️ Summer celebration incoming... Whether sinking hole-in-ones (or giving it our best shot) on the indoor mini-golf course or mingling over refreshing drinks, our Cambridge team definitely knows how to celebrate in style! #WeAre3DS

A new class of biological therapies, nanobodies, has great potential in treating complex diseases. Nanobodies benefit from their small size, unique mechanism of action, and specificity against their target antigens. Dr. Floriane Eshak, Biosciences Postdoctoral Researcher at BIOVIA, talks about her recent publication on successful identification of the epitope of a nanobody that acts as an agonist and a positive allosteric modulator of metabotropic glutamate receptor 5 (mGlu5). The study involves a comparative analysis between physics-based modeling tools in BIOVIA Discovery Studio and AI/deep learning algorithms for structure prediction, and how these methods can be successfully combined to study the binding of drug candidates to their targets and to help design novel biotherapeutics faster. 👇Hear from Dr. Eshak to learn more. Read the full publication, co-authored by Dr. Anne Goupil-Lamy, Life Sciences Fellow at BIOVIA, and their academic collaborators in France: http://go.3ds.com/jiX.

Couldn't attend #BIOVIALive2024 Americas? Here's a recap blog with key highlights to catch you up to speed: http://go.3ds.com/U0k.

Call for abstracts and posters! Present your research and share expertise with industry leaders, scientists and BIOVIA experts at #BIOVIALive2024 Europe in London, UK, from October 15-17. Learn more: http://go.3ds.com/U0E. We welcome submissions in the following areas: ✔ AI and Gen AI ✔ Biopharma Quality and Regulatory ✔ Drug Discovery Development ✔ Formulations ✔ Informatics and Data Science ✔ Lab of the Future ✔ Manufacturing Analytics ✔ Materials Innovation ✔ Molecular Modeling & Simulation

It's time to 'prescribe' a new era with #AI, we're here to transform drug discovery.